Clinical Trial Update: Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS [Phase 2]

View source ↗

Summary

Phase II open-label study assessing the safety and potential efficacy of Triheptanoin in patients with glucose transporter type 1 deficiency syndrome (GLUT1-DS)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Transporter Type Deficiency Syndrome

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Glut1 Deficiency Syndrome | Phase 2 | Status: COMPLETED